Clinical comparison of two low-dose oral contraceptives, Minulet® and Mercilon®, in women over 30 years of age

Contraception

Volumn 49, Issue 1, 1994, Pages 33-46

  Kirkman, R J E ^a   Pedersen, J H ^b   Fioretti, P ^c   Roberts, H E ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b V Strandvej 11 2680 Solrod Strand ^*  (Denmark)

^c UNIVERSITY OF PISA   (Italy)

^d Family Planning Association   (New Zealand)

Author keywords

desogestrel; Low dose oral contraceptives, gestodene; women over 30 years of age

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTODENE;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MIXTURE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; METRORRHAGIA; MULTICENTER STUDY; NAUSEA; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL BLEEDING;

AGE FACTORS--WOMEN; CLINICAL RESEARCH; CLINICAL TRIALS; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTION CONTINUATION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE METHODS--SIDE EFFECTS; CONTRACEPTIVE USAGE; DEMOGRAPHIC FACTORS; DENMARK; DESOGESTREL; DEVELOPED COUNTRIES; DISEASES; EUROPE; FAMILY PLANNING; GESTODENE; ITALY; MEDITERRANEAN COUNTRIES; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDERS; NEW ZEALAND; NORTHERN EUROPE; OCEANIA; ORAL CONTRACEPTIVES, LOW-DOSE--SIDE EFFECTS; ORAL CONTRACEPTIVES--SIDE EFFECTS; POPULATION; POPULATION CHARACTERISTICS; REPRODUCTION; RESEARCH REPORT; SCANDINAVIA; SOUTHERN EUROPE; STUDIES; UNITED KINGDOM;

ADULT; CONTRACEPTIVES, ORAL, COMBINED; DENMARK; ETHINYL ESTRADIOL; FEMALE; GREAT BRITAIN; HUMANS; ITALY; MIDDLE AGED; NEW ZEALAND; NORPREGNENES; PANCURONIUM;

EID: 0028226539     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(94)90107-4     Document Type: Article

References (17)

1. Oral contraceptives and death from myocardial infarction
2. Mortality in women on oral contraceptives
3. Further analysis of mortality in oral contraceptive users
4. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases
5. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraceptive study
6. Desogestrel and gestodene in oral contraception: A review of European experience
7. A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon 30
8. Mercilon—a new, ultra-low dosed oral contraceptive containing 150 mcg desogestrel and 20 mcg ethinyl oestradiol
9. A clinical comparison in Finland of two oral contraceptives containing 0150 mg desogestrel in combination with 0020 mg or 0030 mg ethinyl oestradiol
10. Clinical comparison of two low-dose oral contraceptives in women older than 30 years
11. Efficacy of different contraceptive methods
12. A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives
13. A randomised double-blind trial of two low dose combined oral contraceptives
14. The reduction in risk of ovarian cancer associated with oral contraceptive use
15. Combination oral contraceptive use and the risk of endometrial cancer
16. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives
17. Reversible contraception in the 1980s